High DHODH levels correlate with poor clinical outcomes in colorectal cancer, hepatocellular carcinoma, glioblastoma, and triple-negative breast cancer [13,14,15,16,17]. The gene discussed is DHODH; the disease is hepatocellular carcinoma.